Posted by halcyondaze on February 2, 2007, at 18:40:54
In reply to Re: Why don't they make a transdermal Nardil?, posted by Iansf on February 2, 2007, at 18:15:28
> > Even if it was possible (I don't know whether it is), sales would be too low to justify the expense of development.
> >
> > Ed
>
> I don't see why sales would be lower than for Emsam, nor that it would be any more expensive to develop transdermal Nardil than it was to develop transdermal selegiline.Yes, but remember, EMSAM was supposed to be free of dietary restrictions and therefore much more marketable than Parnate or Nardil.
Though the so-called evidence for EMSAM's dietary restrictions are really not supported (i.e. there were studies where no subjects on any dose followed any kind of diet and there were no hypertensive reactions) and I didn't follow the diet on 9 mg of EMSAM - at all - I ate cheddar and soy and all those lovely foods that would kill me on Parnate, the FDA wanted to be careful.
poster:halcyondaze
thread:728900
URL: http://www.dr-bob.org/babble/20070201/msgs/729158.html